PHYLLIS GARDNER

CIK 1238646 · last filed 2023-06-15

PHYLLIS GARDNER is a corporate insider who has filed 22 SEC Form 4 insider transactions across 4 companies since 2014. The most recent filing, for MDXG, was dated Oct 10, 2024. Across all open-market trades the lifetime net is −$168.0K, making them a net seller over the disclosed history. Current disclosed insider exposure totals $498.5K across reported positions.

"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.

Loading insider history…
Disclosed Exposure

$498.5K

Companies

4

Total Filings

22

Lifetime Open-Market Net

-$168.0K

Holdings By Company

Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
Symbol Role Shares Price Disclosed Exposure Lifetime OM Net Filings Latest Filed
MDXG Director 117,024 $4.26 $498.5K $0 4 2023-06-15
CohBar, Inc. (CWBR) Delisted Director $0.41 $0 2 2021-04-28
Revance Therapeutics, Inc. (RVNC) Delisted Director 460,746 $3.65 $1.68M -$168.0K 8 2020-05-15
Corium International, Inc. (CORI) Delisted Director 0 $0 7 2018-11-28

Recent Filings

22 filings
Insider activity across all companies, newest first. Form 4 rows are post-trade confirmations (buys, sells, grants, exercises). Notice (144) rows are pre-trade notices of intent to sell restricted or control stock under Rule 144 — they may not all execute. Compare adjacent dates to see which notices became actual sales.
Filed Symbol Action Net Shares Net $ Link
2024-10-10 MDXG Notice (144) −30,000 -$165.6K EDGAR
2023-06-15 MDXG Grant (A) +35,354 $175.0K EDGAR
2022-06-13 MDXG Grant (A) +44,191 $175.0K EDGAR
2021-05-28 MDXG Grant (A) +17,056 $175.0K EDGAR
2021-04-29 MDXG Grant (A) +20,423 $218.7K EDGAR
2021-04-28 CohBar, Inc. (CWBR) Delisted Grant (A) $0 EDGAR
2020-05-15 Revance Therapeutics, Inc. (RVNC) Delisted Grant (A) +6,000 $0 EDGAR
2019-05-10 Revance Therapeutics, Inc. (RVNC) Delisted Grant (A) +4,500 $0 EDGAR
2019-02-12 CohBar, Inc. (CWBR) Delisted Grant (A) $0 EDGAR
2018-11-28 Corium International, Inc. (CORI) Delisted Disp (D) −34,203 -$427.5K EDGAR
Showing 110 of 22
Page 1 of 3
Form 4 codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.